secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001628280-24-024334
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners receives Nasdaq bid price deficiency notice; 180-day cure period ends Nov 11, 2024
--------------------------------------------------------------------------------

- Received Nasdaq letter on May 15, 2024 for common stock (PIII) bid price below $1.00 for 31 straight business days.
- Must close at $1.00 or higher for at least 10 consecutive business days by November 11, 2024 to regain compliance.
- If not compliant by Nov 11, may qualify for an additional 180-day period if other listing standards are met.
- Stock remains listed for now; company will evaluate available options to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024024334/0001628280-24-024334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024024334/piii-20240515.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-024334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer